Q1 2025 · 13F-HR
Ikarian Capital, LLCholdings as filed
Filed 2025-05-15 · accession 0001420506-25-001276
$811.5M
Reported value
160
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $179.0M | 22.1% | 320,000 | PUT | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $123.9M | 15.3% | 150,000 | PUT | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $32.9M | 4.05% | 287,900 | PUT | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $24.9M | 3.07% | 485,021 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $22.7M | 2.79% | 655,400 | CALL | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $17.6M | 2.16% | 523,431 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $17.4M | 2.14% | 243,000 | CALL | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $14.0M | 1.72% | 25,000 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $11.4M | 1.41% | 100,000 | CALL | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $10.8M | 1.33% | 169,087 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $10.1M | 1.24% | 113,904 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $9.9M | 1.22% | 245,000 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $8.9M | 1.09% | 300,000 | PUT | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $8.5M | 1.05% | 31,594 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $8.4M | 1.03% | 348,200 | CALL | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $8.3M | 1.02% | 210,065 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $8.3M | 1.02% | 130,000 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $7.9M | 0.97% | 216,989 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $7.9M | 0.97% | 244,179 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $7.6M | 0.93% | 200,000 | Common | SOLE |
| 898202106 | TRUP | TRUPANION INC | $7.5M | 0.92% | 200,000 | CALL | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $7.3M | 0.90% | 111,600 | PUT | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $7.1M | 0.88% | 100,000 | PUT | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $6.9M | 0.85% | 1,068,062 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $6.8M | 0.84% | 400,000 | PUT | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $6.7M | 0.82% | 494,949 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $6.5M | 0.80% | 84,800 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $6.2M | 0.76% | 280,000 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $6.1M | 0.75% | 249,649 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $6.0M | 0.74% | 149,982 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $5.7M | 0.70% | 289,538 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $5.5M | 0.68% | 145,502 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $5.4M | 0.66% | 248,940 | Common | SOLE |
| 02074J501 | ACOG | ALPHA COGNITION INC | $5.1M | 0.63% | 967,867 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $4.8M | 0.60% | 176,800 | PUT | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $4.8M | 0.60% | 100,000 | PUT | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $4.8M | 0.60% | 100,000 | CALL | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $4.8M | 0.59% | 269,090 | Common | SOLE |
| 34962G208 | FBRX | FORTE BIOSCIENCES INC | $4.7M | 0.58% | 609,225 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $4.6M | 0.56% | 264,085 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $4.1M | 0.50% | 113,100 | CALL | SOLE |
| 59267L107 | — | METSERA INC | $4.1M | 0.50% | 150,000 | Common | SOLE |
| 64131A105 | STIM | NEURONETICS INC | $4.0M | 0.50% | 1,100,000 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $3.8M | 0.47% | 400,000 | CALL | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $3.8M | 0.46% | 358,837 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $3.7M | 0.45% | 94,500 | CALL | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $3.7M | 0.45% | 94,500 | PUT | SOLE |
| 45337C102 | INCY | INCYTE CORP | $3.7M | 0.45% | 60,400 | CALL | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $3.6M | 0.45% | 150,000 | CALL | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $3.6M | 0.45% | 100,000 | PUT | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $3.6M | 0.45% | 575,000 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $3.6M | 0.44% | 322,740 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $3.5M | 0.43% | 129,691 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $3.5M | 0.43% | 1,025,221 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $3.2M | 0.40% | 100,000 | CALL | SOLE |
| N90064101 | QURE | UNIQURE NV | $3.2M | 0.39% | 300,000 | CALL | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $3.1M | 0.39% | 90,837 | Common | SOLE |
| 230770109 | CPIX | CUMBERLAND PHARMACEUTICALS I | $3.1M | 0.39% | 740,000 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $3.1M | 0.38% | 200,000 | CALL | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $2.8M | 0.34% | 274,009 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $2.7M | 0.34% | 100,000 | CALL | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $2.6M | 0.33% | 70,700 | PUT | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $2.5M | 0.31% | 533,581 | Common | SOLE |
| 23256X407 | HELP | CYBIN INC | $2.5M | 0.31% | 397,175 | Common | SOLE |
| 451033708 | IBIO | IBIO INC | $2.4M | 0.30% | 599,913 | Common | SOLE |
| 10919W405 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $2.4M | 0.29% | 65,431 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $2.3M | 0.29% | 193,265 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $2.0M | 0.24% | 187,000 | CALL | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $1.9M | 0.24% | 743,308 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $1.9M | 0.24% | 550,029 | Common | SOLE |
| 03969T109 | ARCT | ARCTURUS THERAPEUTICS HLDGS | $1.9M | 0.23% | 175,000 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $1.8M | 0.22% | 649,534 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $1.8M | 0.22% | 175,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $1.6M | 0.20% | 75,000 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $1.6M | 0.20% | 358,393 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $1.6M | 0.20% | 229,900 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $1.6M | 0.20% | 200,000 | Common | SOLE |
| 03969T109 | ARCT | ARCTURUS THERAPEUTICS HLDGS | $1.6M | 0.20% | 150,000 | CALL | SOLE |
| 415858109 | HROW | HARROW INC | $1.6M | 0.19% | 58,300 | CALL | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $1.5M | 0.19% | 601,703 | Common | SOLE |
| 898202106 | TRUP | TRUPANION INC | $1.5M | 0.18% | 40,000 | PUT | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $1.5M | 0.18% | 221,911 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $1.4M | 0.17% | 1,217,590 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $1.3M | 0.16% | 163,363 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $1.3M | 0.16% | 100,365 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $1.3M | 0.16% | 662,200 | CALL | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $1.3M | 0.16% | 662,200 | PUT | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $1.2M | 0.15% | 100,000 | CALL | SOLE |
| 800677106 | SGMO | SANGAMO THERAPEUTICS INC | $1.2M | 0.15% | 1,860,179 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $1.2M | 0.15% | 50,000 | Common | SOLE |
| 02155H200 | ALT | ALTIMMUNE INC | $1.2M | 0.15% | 240,000 | PUT | SOLE |
| 87918A105 | TDOC | TELADOC HEALTH INC | $1.2M | 0.15% | 150,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $1.2M | 0.14% | 950,000 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $1.1M | 0.13% | 253,754 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $1.1M | 0.13% | 619,258 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $1.1M | 0.13% | 338,100 | CALL | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $1.1M | 0.13% | 1,579,528 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $1.0M | 0.13% | 67,927 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $996,445 | 0.12% | 914,170 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $851,435 | 0.10% | 308,491 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $851,001 | 0.10% | 230,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $727,001 | 0.09% | 100,000 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $721,897 | 0.09% | 191,994 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $698,509 | 0.09% | 1,425,239 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $693,022 | 0.09% | 635,800 | CALL | SOLE |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $653,393 | 0.08% | 1,417,952 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $633,709 | 0.08% | 136,575 | Common | SOLE |
| 171126105 | — | CHANNEL THERAPEUTICS CORPORA | $626,004 | 0.08% | 440,849 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $600,927 | 0.07% | 613,253 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $590,716 | 0.07% | 11,900 | CALL | SOLE |
| 45720N103 | INBX | INHIBRX BIOSCIENCES INC | $589,287 | 0.07% | 42,122 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $576,276 | 0.07% | 200,096 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $552,464 | 0.07% | 12,519 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $544,684 | 0.07% | 34,300 | CALL | SOLE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $521,677 | 0.06% | 106,901 | Common | SOLE |
| 09090D301 | — | BIOMX INC | $496,226 | 0.06% | 892,976 | Common | SOLE |
| 55083R104 | — | LYELL IMMUNOPHARMA INC | $471,307 | 0.06% | 876,037 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $469,152 | 0.06% | 78,585 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $445,001 | 0.05% | 250,000 | Common | SOLE |
| 00808Y406 | AEMDEUR | AETHLON MED INC | $440,084 | 0.05% | 1,229,285 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $403,389 | 0.05% | 39,900 | PUT | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $378,001 | 0.05% | 175,000 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $366,742 | 0.05% | 62,691 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $347,001 | 0.04% | 100,000 | Common | SOLE |
| 37611X209 | DNA | GINKGO BIOWORKS HOLDINGS INC | $332,310 | 0.04% | 58,300 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $325,500 | 0.04% | 35,000 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $323,070 | 0.04% | 17,800 | PUT | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $323,070 | 0.04% | 17,800 | CALL | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $292,345 | 0.04% | 265,769 | Common | SOLE |
| 816212302 | RNAC | CARTESIAN THERAPEUTICS INC | $292,149 | 0.04% | 22,166 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $290,100 | 0.04% | 1,000,000 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $266,736 | 0.03% | 1,171,950 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $238,500 | 0.03% | 150,000 | Common | SOLE |
| 16385C104 | — | CHEMOMAB THERAPEUTICS LTD | $232,226 | 0.03% | 213,052 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $230,877 | 0.03% | 150,900 | Common | SOLE |
| 61023L207 | MNPR | MONOPAR THERAPEUTICS INC | $215,111 | 0.03% | 5,908 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $213,608 | 0.03% | 175,088 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $210,750 | 0.03% | 150,000 | Common | SOLE |
| 034569103 | ANEB | ANEBULO PHARMACEUTICALS INC | $205,036 | 0.03% | 157,720 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $188,489 | 0.02% | 55,766 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $178,792 | 0.02% | 690,050 | Common | SOLE |
| 81728A108 | SNSEEUR | SENSEI BIOTHERAPEUTICS INC | $177,285 | 0.02% | 449,963 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $159,000 | 0.02% | 50,000 | PUT | SOLE |
| 15102K100 | CELC | CELCUITY INC | $150,639 | 0.02% | 14,900 | CALL | SOLE |
| 29970R303 | EVAX | EVAXION BIOTECH A/S | $148,000 | 0.02% | 80,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $145,168 | 0.02% | 50,058 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $133,645 | 0.02% | 1,058,148 | Common | SOLE |
| 87164U508 | TOVX | THERIVA BIOLOGICS INC | $132,034 | 0.02% | 120,031 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $125,830 | 0.02% | 58,526 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $107,959 | 0.01% | 25,107 | Common | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $101,941 | 0.01% | 27,257 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $101,691 | 0.01% | 80,071 | Common | SOLE |
| 02080L102 | TKNO | ALPHA TEKNOVA INC | $72,701 | 0.01% | 14,008 | Common | SOLE |
| 68232V884 | TRAW | TRAWS PHARMA INC | $65,534 | 0.01% | 28,493 | Common | SOLE |
| 43906K209 | HOOK | HOOKIPA PHARMA INC | $57,236 | 0.01% | 52,996 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $39,067 | 0.00% | 11,984 | Common | SOLE |
| 05330T205 | AMIX | AUTONOMIX MED INC | $35,001 | 0.00% | 20,000 | Common | SOLE |
| 87166L209 | SYBX | SYNLOGIC INC | $25,323 | 0.00% | 20,422 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $15,457 | 0.00% | 15,457 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $10,873 | 0.00% | 40,270 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.